These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24780721)

  • 21. Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience.
    Topaz M; Seger DL; Slight SP; Goss F; Lai K; Wickner PG; Blumenthal K; Dhopeshwarkar N; Chang F; Bates DW; Zhou L
    J Am Med Inform Assoc; 2016 May; 23(3):601-8. PubMed ID: 26578227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support.
    Seidling HM; Phansalkar S; Seger DL; Paterno MD; Shaykevich S; Haefeli WE; Bates DW
    J Am Med Inform Assoc; 2011; 18(4):479-84. PubMed ID: 21571746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts.
    Nishimura AA; Shirts BH; Salama J; Smith JW; Devine B; Tarczy-Hornoch P
    Int J Med Inform; 2016 Feb; 86():117-25. PubMed ID: 26642939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts.
    Shah SN; Amato MG; Garlo KG; Seger DL; Bates DW
    J Am Med Inform Assoc; 2021 Jun; 28(6):1081-1087. PubMed ID: 33517413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.
    Weingart SN; Seger AC; Feola N; Heffernan J; Schiff G; Isaac T
    Drug Saf; 2011 Jul; 34(7):587-93. PubMed ID: 21663334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts.
    McDaniel RB; Burlison JD; Baker DK; Hasan M; Robertson J; Hartford C; Howard SC; Sablauer A; Hoffman JM
    J Am Med Inform Assoc; 2016 Apr; 23(e1):e138-41. PubMed ID: 26499101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing clinical decision support alerts in electronic medical records: a systematic review of reported strategies adopted by hospitals.
    Van Dort BA; Zheng WY; Sundar V; Baysari MT
    J Am Med Inform Assoc; 2021 Jan; 28(1):177-183. PubMed ID: 33186438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot evaluation of a method to assess prescribers' information processing of medication alerts.
    Russ AL; Melton BL; Daggy JK; Saleem JJ
    J Biomed Inform; 2017 Feb; 66():11-18. PubMed ID: 27908833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study.
    Cornu P; Phansalkar S; Seger DL; Cho I; Pontefract S; Robertson A; Bates DW; Slight SP
    Int J Med Inform; 2018 Mar; 111():165-171. PubMed ID: 29425628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit.
    Wong A; Amato MG; Seger DL; Rehr C; Wright A; Slight SP; Beeler PE; Orav EJ; Bates DW
    BMJ Qual Saf; 2018 Sep; 27(9):718-724. PubMed ID: 29440481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-priority drug-drug interactions for use in electronic health records.
    Phansalkar S; Desai AA; Bell D; Yoshida E; Doole J; Czochanski M; Middleton B; Bates DW
    J Am Med Inform Assoc; 2012; 19(5):735-43. PubMed ID: 22539083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. User-centered design improves the usability of drug-drug interaction alerts: Experimental comparison of interfaces.
    Luna DR; Rizzato Lede DA; Otero CM; Risk MR; González Bernaldo de Quirós F
    J Biomed Inform; 2017 Feb; 66():204-213. PubMed ID: 28108211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Medication Alerts on Prescriber Response in a Pediatric Hospital.
    Dexheimer JW; Kirkendall ES; Kouril M; Hagedorn PA; Minich T; Duan LL; Mahdi M; Szczesniak R; Spooner SA
    Appl Clin Inform; 2017 May; 8(2):491-501. PubMed ID: 28487930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care.
    Tamblyn R; Huang A; Taylor L; Kawasumi Y; Bartlett G; Grad R; Jacques A; Dawes M; Abrahamowicz M; Perreault R; Winslade N; Poissant L; Pinsonneault A
    J Am Med Inform Assoc; 2008; 15(4):430-8. PubMed ID: 18436904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: a systematic review.
    Hussain MI; Reynolds TL; Zheng K
    J Am Med Inform Assoc; 2019 Oct; 26(10):1141-1149. PubMed ID: 31206159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Late Attempt to Involve End Users in the Design of Medication-Related Alerts: Survey Study.
    Baysari MT; Zheng WY; Van Dort B; Reid-Anderson H; Gronski M; Kenny E
    J Med Internet Res; 2020 Mar; 22(3):e14855. PubMed ID: 32167479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.